Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin

• Auteurs principaux: Weijia Li (Auteur), Xibo Zhao (Auteur), Rujian Zhang (Auteur), Jiabin Xie (Auteur), Guangmei Zhang (Auteur)
• Format: Livre
• Publié: Hindawi Limited, 2023-01-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background. Ovarian cancer is a fatal gynecological malignancy. The resistance to chemotherapy in ovarian cancer treatment has been a thorny issue. This study is aimed at probing the molecular mechanism of cisplatin (DDP) resistance in ovarian cancer. Methods. Bioinformatics analysis was conducted t...